6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Acute Promyelocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohle, DS; Colombo, M; Diaz, Z; Mann, KK; Miller, WH; Schipper, HM; Smith, KN; Su, H | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines.
Topics: Annexin A5; Antioxidants; Apoptosis; Arsenic; Cell Division; Cell Line, Tumor; Chromans; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Promyelocytic, Acute; Membrane Proteins; Oxidative Stress | 2005 |